SCHEMBL6164718

SCHEMBL6164718

CC(C)c1nn(CCO)c2c1C(=O)CC(C)(C)C2

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.41
ALPL P05186 1/20 0.40
HDAC1 Q13547 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
BUB1 O43683 1/20 0.38
HDAC4 P56524 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
OPRM1 P35372 9/20 0.36
KMT2A Q03164 2/20 0.36
HSD17B10 Q99714 1/20 0.36
ALDH1A1 P00352 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6165525 0.82 HTT (0.61) HTTHDAC1HDAC6OPRM1KMT2A
SCHEMBL6166123 0.82 ALPL (0.43) HTTALPLHDAC1HDAC6BUB1
SCHEMBL6166935 0.80 OPRM1 (0.39) HTTALPLCRHBPCRHR2OPRM1
SCHEMBL6164113 0.78 OPRM1 (0.49) HTTALPLHDAC1HDAC6BUB1
SCHEMBL6164100 0.78 HDAC1 (0.45) HTTALPLHDAC1HDAC6BUB1
SCHEMBL6164656 0.78 HTT (0.68) HTTBUB1OPRM1
SCHEMBL6162828 0.77 ALPL (0.63) HTTALPLHDAC1HDAC6BUB1
SCHEMBL6165665 0.76 ALPL (0.39) HTTALPLHDAC1HDAC6BUB1
SCHEMBL6164263 0.76 HTT (0.41) HTTBUB1
SCHEMBL6163627 0.75 HTT (0.40) HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed